Main Street Group’s Emergent Biosolutions EBS Stock Holding History

Main Street Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-125	Closed	-$883	–	809
2024 Q2	$883	Hold	125	–	–	﹤0.01%	773
2024 Q1	$288	Hold	125	–	–	﹤0.01%	861
2023 Q4	$300	Buy	+125	New	+$294	﹤0.01%	1226

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Main Street Group's EBS Position: Q3 2024 in Review

Main Street Group sold out of Emergent Biosolutions (EBS) in Q3 2024, closing a stake of 125 shares — an estimated $883 sold.

Main Street Group first reported a position in EBS in Q4 2023 and held it in 3 quarters. The position peaked at $883 in Q2 2024. 140 funds tracked by Wall St. Rank hold EBS as of Q3 2024.

Main Street Group reported no remaining Emergent Biosolutions position as of Q3 2024 after selling out during the quarter.
Main Street Group sold 125 Emergent Biosolutions shares in Q3 2024, an estimated $883.
Main Street Group first reported a position in Emergent Biosolutions in Q4 2023 and held it in 3 quarters.
Main Street Group's Emergent Biosolutions position peaked at $883 in Q2 2024.
140 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2024.

Based on Main Street Group's 13F filing for Q3 2024, filed 13 Nov 2024.